Forbes September 18, 2024
Plus: Will the Feds negotiate Ozempic prices?
Healthcare AI startups developing products geared towards hospital systems have raised $23.2 billion over the past decade, according to a recent analysis by Flare Capital Partners. The biggest chunk of funding at $11.5 billion has gone to 324 companies working on solutions that impact clinical care. The flow of venture capital money, speed of technology advancement and the resources of Big Tech companies like Microsoft, Amazon and Apple have raised questions about who’s really going to drive the healthcare AI regulatory agenda: industry or the feds?
“There is a risk that the system’s going to outrun the ability to regulate it, but it will eventually self-correct,” FDA Commissioner Robert Califf told reporters at...
Today's Sponsors
Today's Sponsor